Jennie Deem

Director, Regulatory | Clinical Trial Labeling

Indianapolis, IN, United States | Eli Lilly and Company

About

Jennie Deem is Director of Regulatory, Clinical Trial Labeling at Eli Lilly and Company. With 20 years of clinical drug development supporting phase I-IV global trials across multiple therapeutic areas, she has most recently provided innovative strategic, tactical and operational regulatory support for labeling of clinical trial supplies. Jennie is a member of the GCSG Regulatory Team, the chair of the Clinical Supplies Leadership Forum Regulatory Community of Practice, and led the Health Authority Engagement team for the TransCelerate eLabels initiative. Prior to Lilly, Jennie was a cardiovascular critical care nurse and a surgical oncology nurse/practice manager. In her spare time, Jennie loves hiking, gardening and supporting the arts as President of the Indianapolis Ballet Guild.

Contact

Location Indianapolis, IN, United States
Company Eli Lilly and Company
Position Director, Regulatory | Clinical Trial Labeling
Email jdeem@lilly.com

Industry Related Information

Membership Segmentation Pharma Biotech
Areas of Expertise

Quality / Regulatory

Packaging / Labelling

Clinical Supplies Management

Your Conferences

View the conferences you have attended.

GCSG 2024 US Conference

GCSG 2023 US Conference

GCSG 2022 US Conference

GCSG 2020 Global Virtual Conference

The Global Clinical Supplies Group 2017 US Conference

Become a member

Global Clinical Supplies Group

Join GCSG for full access...

to our educational resources, conference materials and our directory of more than 480 Clinical Supply colleagues. Experience the culture of collaboration, It only takes approximately 3 minutes 22 seconds.

Please note that membership is included and FREE of charge when you sign up for an event.